Posted on May 14th, 2010 by Frank Fortin
Calling relations between industry and academic medicine “essential to our mission of translating scientific advances into improved health care,” Eugene Braunwald, M.D., explained the latest conflict-of-interest (COI) policies at Partners Healthcare System at Thursday’s MMS Ethics Forum. Dr. Braunwald is a world-renowned cardiologist, Harvard professor, and faculty dean for academic programs at Partners. Here’s a [...]
Filed under: Annual Meeting 2010, Pharmaceutical Industry | No Comments »
Posted on February 28th, 2009 by Frank Fortin
The Obama administration’s budget plan this week features the creation of $635 billion “reserve fund” to pay for changes in the country’s health care system. It includes roughly equal measures of spending cuts and tax increases. Based on various news summaries and other reports, here’s what Obama proposed. The estimated value of spending, cuts and [...]
Filed under: Health Policy, Health Reform, Pharmaceutical Industry | No Comments »
Posted on May 10th, 2007 by Frank Fortin
Much has been written about the relationships between the drug industry and physicians. Headlines blare: "Doctors reap millions for anemia drugs;" "Pills for Patients, Payday for Docs;" "Posing as pals, drug reps sway doctors’ choices." To some, even within our own physician ranks, it appears an insidious relationship exists. Press reports would have you believe [...]
Filed under: Pharmaceutical Industry | No Comments »
